Safety of KAE609 in Adults With Uncomplicated Plasmodium Falciparum Malaria.
Clinical trial NCT03334747 · COMPLETED
Trial details
- NCT number
- NCT03334747
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-16
- Primary completion
- 2019-11-23
- Enrollment
- 188
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.